ArticleAngewandte Chemie (International ed. in English)2026
Probing Into Asymmetric Dearomatizing Photocycloadditions of 2-Naphthalene Derivatives With Alkenes: [2 + 2] and [4 + 2] Pathways.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Catalytic dearomative photocycloaddition stands as one of the most powerful strategies for constructing highly complex, three-dimensional polycyclic scaffolds from readily accessible planar aromatic precursors. However, achieving asymmetric variants of these transformations with simple alkenes remains a formidable challenge, as it demands precise control over regio-, diastereo-, and enantioselectivity. Herein, we report asymmetric dearomatizing [2 + 2] and [4 + 2] photocycloadditions of 2-naphthalene derivatives by chiral terbium(III)/N,N'-dioxide complexes, wherein a pronounced ligand-acceleration effect is operative. The selectivity between the two pathways is governed by reaction temperature, alkene stoichiometry, and reaction time, thereby enabling the divergent synthesis of chiral cyclobutane-fused adducts (46 examples, up to 99% yield, > 19:1 dr, 99% ee) and bridged adducts (41 examples, up to 99% yield, up to 12:1 dr, 99% ee) with high efficiency. Notably, both cycloaddition manifolds accommodate terminal and internal olefins. Mechanistic investigations elucidate the origin of the ligand-acceleration effect and establish a kinetic basis for ortho-selectivity in the [2 + 2] pathway and a thermodynamic basis for para-selectivity in the [4 + 2] pathway. Density functional theory calculations further rationalize the competitive interplay between [2 + 2] and [4 + 2] cycloadditions and provide insight into the stereochemical outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.